StuartMLevitzMD
Infectious Disease • Worcester, MAProfessor, Medicine, University Massachusetts Medical School
Are you Dr. Levitz?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 41 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
55 Lake Ave N
Worcester, MA 01655Phone+1 774-441-8230Fax+1 508-334-3428
Summary
- Dr. Stuart Levitz, MD is an infectious disease specialist in Worcester, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is affiliated with UMass Memorial Medical Center and is a Professor at University Massachusetts Medical School.
Education & Training
Boston University Medical CenterFellowship, Infectious Disease, 1982 - 1984
New York University School of MedicineClass of 1979
Certifications & Licensure
MA State Medical License 1982 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 152 citationsChitin recognition via chitotriosidase promotes pathologic type-2 helper T cell responses to cryptococcal infection.Darin L. Wiesner, Charles A. Specht, Chrono K. Lee, Kyle D. Smith, Liliane Mukaremera
Plos Pathogens. 2015-03-12 - 457 citationsHistatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida alb...Frank G. Oppenheim, Tao Xu, F. M. Mcmillian, Stuart M. Levitz, Richard D. Diamond
The Journal of Biological Chemistry. 1988-06-05 - 89 citationsActivation of C3 and binding to Aspergillus fumigatus conidia and hyphae.Thomas R. Kozel, M A Wilson, T P Farrell, Stuart M. Levitz
Infection and Immunity. 1989-11-01
Press Mentions
New Antifungal Medications Are Sorely NeededJanuary 18th, 2022- Valley Fever Vaccine for Dogs Shows Promising Results, First Step Toward Human TrialsNovember 5th, 2021
- How COVID-19 Created a Perfect Storm for a Deadly Fungal Infection in IndiaJune 22nd, 2021
- Join now to see all
Grant Support
- Immunostimulatory Properties Of Chitin And ChitosanNational Institute Of Allergy And Infectious Diseases2011
- 2011 Immunology Of Fungal Infections Gordon Research ConferenceNational Institute Of Allergy And Infectious Diseases2011
- Immune Response To Cryptococcal InfectionsNational Institute Of Allergy And Infectious Diseases2006–2011
- Model Vaccines Exploiting Fungal MannosylationNational Institute Of Allergy And Infectious Diseases2006–2009
- Model Vaccines Exploiting Fungal MannosylationNational Institute Of Allergy And Infectious Diseases2005–2006
- Immune Response To Cryptococcal InfectionsNational Institute Of Allergy And Infectious Diseases1994–2006
- 6th International Conf. On Cryptococcus &CryptococcosisNational Institute Of Allergy And Infectious Diseases2005
- Macrophage Interactions With C. NeoformansNational Institute Of Allergy And Infectious Diseases2001–2005
- (1. Chloroquine As Immunotherapty For CryptococcosisFogarty International Center1998–2000
- Macrophage Interactions With C NeoformansNational Institute Of Allergy And Infectious Diseases1996–2000
- Receptor-Ligand Interactions In CryptococcosisNational Institute Of Allergy And Infectious Diseases1994
- Immune Response To Cryptococcal InfectionsNational Institute Of Allergy And Infectious Diseases1993
- Receptor-Ligand Interactions In CryptococcosisNational Institute Of Allergy And Infectious Diseases1990–1993
- Role Of Macrophages In Cryptococcal InfectionsNational Institute Of Allergy And Infectious Diseases1987–1992
- Mechanisms Of Neutrophil-Aspergillus InteractionsNational Institute Of Allergy And Infectious Diseases1985–1989
- Host Defense Mechanisms Against Opportunistic MycosesNational Institute Of Allergy And Infectious Diseases1985
